Overview of the Financial Setback
The pension schemes for pharmacists and dentists in Schleswig-Holstein have encountered significant financial challenges due to their involvement in a property development project located in Frankfurt’s prominent banking district. The ambitious Canyon office project on Mainzer Landstrasse, featuring 40,000 square metres of office space spread over 14 floors, has led to substantial financial losses for both pension schemes. According to reports from Handelsblatt, each scheme had to write off over 50 million euros in 2023, with additional losses anticipated in 2024.
Impact on Pension Schemes
As a consequence of these financial setbacks, the pharmacists’ pension scheme was unable to implement any increases in pensions, while the dentists’ scheme was compelled to tap into their interest rate change reserves. Despite repeated inquiries, both pension funds have refrained from commenting publicly on the situation.
Investment Decisions and Consequences
The initial investment by the pension funds included direct company participations, shareholder loans, and mezzanine financing. Each fund initially held a ten percent stake in the project, but as financial difficulties arose due to rising interest rates and a lack of tenants, the funds increased their investments. By summer 2023, the dentists’ pension fund had increased its share to 15 percent. By early February 2024, the total joint share escalated to 35 percent, with the pharmacists holding 15 percent and the dentists 20 percent. However, a restructuring in the summer of 2024 saw Anglo-Saxon investment manager Tite Street Capital take over the majority stake, significantly reducing the pension funds’ shares to 5.04 percent for pharmacists and 7.56 percent for dentists.
Financial Losses and Future Prospects
During an extraordinary meeting of the dentists’ pension scheme in September 2024, Thomas Kriens, the chairman of the supervisory committee, reported losses of approximately 46 million euros. Kriens had already forewarned mid-2024 that the Canyon property project would negatively impact the 2024 financial year by an additional 7.7 million euros. Although the exact financial impact on the pharmacists’ pension scheme remains undisclosed, the scheme’s 2023 annual report hinted at the financial strain, citing the lack of an anchor tenant and non-repayment of a granted loan, leading to a full write-off, including interest.
Despite the optimism expressed by Tite Street Capital, intending to continue the project, the pension funds have already incurred significant losses. The majority of the invested capital has dissipated, and the remaining shareholder stakes offer scant hope for future returns.
